Generex Biotechnology (OTCMKTS:GNBT) Shares Cross Above Two Hundred Day Moving Average of $0.29

Generex Biotechnology Co. (OTCMKTS:GNBT) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.29 and traded as high as $0.29. Generex Biotechnology shares last traded at $0.29, with a volume of 526,119 shares changing hands.

The company has a quick ratio of 0.03, a current ratio of 0.04 and a debt-to-equity ratio of 0.45. The firm has a market cap of $33.61 million, a P/E ratio of -0.66 and a beta of -2.64. The stock’s 50-day simple moving average is $0.29 and its 200 day simple moving average is $0.29.

Generex Biotechnology (OTCMKTS:GNBT) last issued its quarterly earnings results on Wednesday, March 17th. The company reported ($0.08) EPS for the quarter. Generex Biotechnology had a negative net margin of 1,722.93% and a negative return on equity of 1,712.86%.

Generex Biotechnology Company Profile (OTCMKTS:GNBT)

Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an oral insulin product. The company is also developing AE37, a synthetic peptide vaccine, which has completed Phase IIb clinical trial to stimulate a potent and specific immune response against tumors expressing the HER-2/neu oncogene in patients with breast cancer and prostate cancer.

See Also: Pattern Day Trader

Receive News & Ratings for Generex Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Generex Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.